Skip to content
ITIF Logo
ITIF Search

Publications: Stephen Ezell

March 30, 2026

Mobilizing for Techno-Economic War, Part 2: Slowing China’s Advance

Boosting U.S. competitiveness in national power industries is necessary, but not sufficient to avoid losing to China. America also must take measures to slow the PRC’s progress toward global dominance. This report provides more than 100 actionable recommendations for the administration and Congress. Western allies should take many of the same steps.

March 23, 2026

Assessing the Evolving Global Competitiveness of the US Auto Industry

To win the techno-economic competition with China, America must be able to assess the factors impacting the global competitiveness of its advanced-technology industries. Using the auto industry as a template, U.S. competitiveness has faltered considerably.

March 18, 2026

Comments to the US Treasury Department Regarding the CFIUS Known Investor Program and Foreign Investment Review Process

CFIUS’ procedures need to be strengthened to ensure that Chinese entities, particularly those influenced or backed by Chinese government influence or funding, cannot acquire U.S. companies or technology that could harm America’s economic or national security.

March 18, 2026

Lessons From Europe’s Loss of Biopharma Leadership, and Its Attempts to Recover

Europe once led the world in biopharmaceutical innovation, but it lost ground after adopting policies that weakened incentives for R&D and innovation. America must learn from Europe’s experience to preserve its own biopharma leadership and the related economic benefits and access to the most innovative drugs.

March 17, 2026

Testimony to the House Ways and Means Trade Subcommittee Regarding Advancing America’s Interest at the WTO’s 14th Ministerial Conference

The United States should use MC14 to push for a WTO that actively promotes fair market competition—not one that passively accepts non-market policies, overcapacity, and coercive distortions that are undermining the global trading system.

February 23, 2026

Comments to Department of Health and Human Services Regarding the Proposed GUARD Model

The international reference pricing-based GUARD model lacks a sound premise for its rationale, is fundamentally flawed in its design, and should be withdrawn in full by CMS.

February 23, 2026

Comments to Department of Health and Human Services Regarding the Proposed GLOBE Model

The international reference pricing-based GLOBE model lacks a sound premise for its rationale, is fundamentally flawed in its design, and should be withdrawn in full by CMS.

January 22, 2026

Trump Is Correct: European Nations Must Pay More for Innovative Drugs

Europe has long free-ridden on U.S. drug innovation—and while President Trump is right to push allies to pay their fair share, importing Europe’s price controls into the U.S. would undercut the very innovation the world depends on.

January 5, 2026

Top 10 Tech Policy Pronouncements, Prognostications, and Questions for 2026

If the year ahead in technology and innovation policy lives up to its potential, it could be a consequential one because there is a long list of important issues on the table. Herein, we offer 10 that are on top of our minds.

December 18, 2025

Comments to OSTP Regarding Accelerating the American Scientific Enterprise

The science community must move beyond the linear model of scientific research developed and encouraged by Vannevar Bush, and realign scientific exploration with national interests, especially in the face of the growing technological and economic threat posed by China.

Back to Top